St. Jude Medical Inc.’s neurostimulation unit got a boost this week with two new US FDA approvals.
The first approval, announced Oct. 4, went to spinal cord stimulation system BurstDR, which is used to treat chronic pain patients. St. Jude says the physician-designed system uses intermittent “burst”...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?